AVID BIOSERVICES, INC. (NASDAQ: CDMO) Files An 8-K Results of Operations and Financial Condition
ITEM 2.02RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On December 10, 2018, Avid Bioservices, Inc. (the “Company”) issued a press release to report the Company’s financial results for the second quarter ended October 31, 2018. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1. No additional information is included in this Current Report on Form 8-K.

The information included in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed “filed” for purposes of, nor shall it be deemed incorporated by reference in, any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.

ITEM 7.01REGULATION FD DISCLOSURE

On December 10, 2018, at 4:30 p.m. EST/1:30 p.m. PST, the Company will host a conference call to discuss its second quarter ended October 31, 2018 financial results. The webcast of the conference call will be archived on the Company’s website for approximately 30 days.

ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K:

Exhibit

Number

99.1Press Release issued December 10, 2018.

Avid Bioservices, Inc. Exhibit
EX-99.1 2 avid_ex9901.htm PRESS RELEASE Exhibit 99.1     Contacts:       Stephanie Diaz (Investors)   Tim Brons (Media)   Vida Strategic Partners   Vida Strategic Partners   415-675-7401   415-675-7402   [email protected]   [email protected]     Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2019 and Recent Developments   — Fiscal 2019 Projected Revenue of $51 to $55 Million Reaffirmed —   — Signed Project Expansion Orders for $6.3 Million with Current Customers —   — Successfully Executed Scheduled Broad Scale Facilities Maintenance and Upgrade Program —   TUSTIN,…
To view the full exhibit click here